日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biofabrication of pheochromocytoma and paraganglioma tumor organoids and assessment of response to systemic therapy.

嗜铬细胞瘤和副神经节瘤肿瘤类器官的生物制造及对全身治疗反应的评估。

Erali Richard A, Forsythe Steven D, Schaaf Cecilia R, Edenhoffer Nicholas, Meeker William, Valenzuela Cristian D, Li Wencheng, Soker Shay, Randle Reese W, Votanopoulos Konstantinos I

Lightweight Multimodal Fusion for Urban Tree Health and Ecosystem Services

用于城市树木健康和生态系统服务的轻量级多模态融合

Buriboev, Abror; Sultanov, Djamshid; Rahmatullaev, Ilhom; Yusupov, Ozod; Eshonqulov, Erali; Bekmuradov, Dilshod; Egamberdiev, Nodir; Choi, Andrew Jaeyong

Enhancing the Efficacy of HIPEC Through Bromelain: A Preclinical Investigation in Appendiceal Cancer

通过菠萝蛋白酶增强 HIPEC 的疗效:阑尾癌的临床前研究

Nadeem Wajih, Richard A Erali, Steven D Forsythe, Cecilia R Schaaf, Perry Shen, Edward A Levine, Shay Soker, David L Morris, Konstantinos I Votanopoulos

Cisplatin exhibits superiority over MMC as a perfusion agent in a peritoneal mesothelioma patient specific organoid HIPEC platform

在针对腹膜间皮瘤患者的特定类器官 HIPEC 平台中,顺铂作为灌注剂优于 MMC

Steven D Forsythe, Richard A Erali, Nicholas Edenhoffer, William Meeker, Nadeem Wajih, Cecilia R Schaaf, Preston Laney, Cristian D Vanezuela, Wencheng Li, Edward A Levine, Shay Soker, Konstantinos I Votanopoulos

Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center

在一家高容量中心,采用细胞减灭术和腹腔热灌注化疗治疗腹膜间皮瘤患者的长期生存率

Valenzuela, Cristian D; Solsky, Ian B; Erali, Richard A; Forsythe, Steven D; Mangieri, Christopher W; Mainali, Bigyan B; Russell, Gregory; Perry, Kathleen C; Votanopoulos, Konstantinos I; Shen, Perry; Levine, Edward A

Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)

子宫肌层浸润对细胞减灭术联合腹腔热灌注化疗(CRS-HIPEC)后生存结局的影响

Mangieri, Christopher W; Valenzuela, Cristian D; Solsky, Ian B; Erali, Richard A; Votanopoulos, Konstantinos I; Shen, Perry; Levine, Edward A

Utilizing Patient-Derived Organoids in the Management of Colorectal Cancer with Peritoneal Metastases: A Review of Current Literature

利用患者来源的类器官治疗伴有腹膜转移的结直肠癌:当前文献综述

Erali, Richard A; Forsythe, Steven D; Gironda, Daniel J; Schaaf, Cecilia R; Wajih, Nadeem; Soker, Shay; Votanopoulos, Konstantinos I

Application of immune enhanced organoids in modeling personalized Merkel cell carcinoma research

免疫增强类器官在个性化默克尔细胞癌研究中的应用

Steven D Forsythe, Richard A Erali, Preston Laney, Hemamylammal Sivakumar, Wencheng Li, Aleksander Skardal, Shay Soker, Konstantinos I Votanopoulos

ASO Author Reflections: Sarcoma Organoids: Neutralizing the Word "Rare" in Rare Cancers

ASO作者反思:肉瘤类器官:消除罕见癌症中“罕见”一词的固有印象

Forsythe, Steven D; Sivakumar, Hemamylammal; Erali, Richard A; Skardal, Aleksander; Votanopoulos, Konstantinos I

Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications

用于个性化转化研究的患者特异性肉瘤类器官:手术室与罕见癌症研究的统一及其临床意义

Steven D Forsythe #, Hemamylammal Sivakumar #, Richard A Erali, Nadeem Wajih, Wencheng Li, Perry Shen, Edward A Levine, Katherine E Miller, Aleksander Skardal, Konstantinos I Votanopoulos8